thyroid disease: A disease involving the thyroid gland.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
461 |
4. Check minimum number of eventsNone |
461 |
5. Include endpointsNone |
461 |
6. Filter based on genotype QC (FinnGen only) |
461 |
Control definitions (FinnGen only)
- Control exclude
- E4_THYROID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorder of thyroid, unspecified
based on the number of shared cases.
Similar with more cases:
- Other disorders of thyroid
- Disorders of thyroid, IBD co-morbidities
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3547 | 2760 | 749 |
| Only index persons | 2885 | 2275 | 610 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.08 | 0.02 |
| Only index persons | 0.07 | 0.08 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 47.04 | 46.23 | 49.67 |
| Only index persons | 43.39 | 42.46 | 46.83 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 461 | 379 | 82 |
| Unadjusted period prevalence (%) | 0.11 | 0.13 | 0.04 |
| Median age at first event (years) | 43.64 | 41.67 | 52.70 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 392
- Matched controls
- 3921
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
2601.8
175.9
157
*
H03AA01
ATC
levothyroxine sodium; systemic
71.9
171.5
193
52
24599
ICD-8 Finland
Thyroiditis, Unspecified
+∞
139.0
125
*
104
Kela drug reimbursment
Thyroid insufficiency
1094.6
91.7
86
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
159.0
84.9
87
7
E07.89
ICD-10 Finland
Other specified disorders of thyroid
+∞
74.4
69
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
173.1
44.8
46
*
E03
ICD-10 Finland
Other hypothyroidism
179.6
32.2
33
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
65.8
31.6
36
6
E03.89
ICD-10 Finland
Other specified hypothyroidism
119.7
31.2
33
*
H03BB01
ATC
carbimazole; oral
289.8
27.1
27
*
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
289.8
27.1
27
*
BAA60
NOMESCO Finland
Total thyroidectomy
243.6
22.9
23
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
+∞
22.1
21
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
33.3
21.8
28
9
T86
ICPC
Hypothyroidism/myxoedema
39.6
21.0
26
7
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
+∞
21.0
20
*
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
+∞
17.8
17
*
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
+∞
15.7
15
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
51.8
12.9
15
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.4
12.7
38
76
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
22.1
12.1
17
8
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
18.5
10.8
16
9
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
112.9
10.5
11
*
E07.81
ICD-10 Finland
Pituitary thyroxin resistence
+∞
10.5
10
*
E07.82
ICD-10 Finland
Disorder of thyroid function caused by general disease state
+∞
10.5
10
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
+∞
10.5
10
*
E06.1
ICD-10 Finland
Subacute thyroiditis
+∞
10.5
10
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
16.6
10.4
16
10
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
33.5
10.4
13
*
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
+∞
9.4
9
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
+∞
8.4
8
*
2469X
ICD-9 Finland
Other disorders of thyroid, Unspecified disorder of thyroid
+∞
8.4
8
*
E07.8
ICD-10 Finland
Other specified disorders of thyroid
+∞
8.4
8
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
81.6
7.4
8
*
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
30.6
7.2
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
6.6
117
724
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
6.4
147
991
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.3
147
992
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
+∞
6.3
6
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
6.3
6
*
E07.80
ICD-10 Finland
Pituitary thyroxin resistence
+∞
6.3
6
*
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
+∞
6.3
6
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.8
6.2
122
777
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
101
115
10.97
84.47
4.0
1.5
pmol/l
4.7
4.4
0.84
96
101
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
45
45
10.97
40.43
2.2
1.2
iu/l
2.6
0.7
—
18
5
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
393
2870
3.50
21.85
7.6
2.6
pmol/l
15.7
14.4
10.28
374
2574
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
68
193
3.96
21.42
1.4
1.2
iu/ml
127.9
87.5
0.40
26
69
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
267
1810
2.13
13.92
8.2
5.5
mmol/l
1.2
1.2
0.19
234
1548
(3036481) Cortisol [Moles/volume] in Serum or Plasma
74
294
2.81
13.33
2.3
1.8
nmol/l
378.4
363.5
0.26
69
267
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
419
3467
3.29
13.29
8.8
3.5
mu/l
1.9
1.9
0.10
398
3140
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
81
4.17
11.67
1.3
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
238
1641
1.93
10.81
7.7
4.7
mmol/l
1.2
1.2
0.40
221
1488
(3013707) Erythrocyte sedimentation rate by Westergren method
355
2827
2.11
10.36
4.8
4.1
mm/h
12.2
12.1
0.04
336
2599
(3044640) Blood type and Crossmatch panel - Blood
182
1168
1.92
10.08
2.1
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
147
886
1.97
9.75
2.0
2.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
171
1098
1.89
9.30
4.5
3.3
ph
7.4
7.4
0.37
31
204
(3015377) Calcium [Moles/volume] in Serum or Plasma
191
1271
1.86
9.28
3.0
3.3
mmol/l
2.3
2.4
0.97
172
1107
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
240
1740
1.79
8.59
4.0
3.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
58
254
2.47
8.50
2.6
3.0
ng/l
69.4
81.6
0.75
50
224
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
222
1615
1.72
7.52
2.6
2.2
nmol/l
78.4
78.5
0.01
206
1438
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
207
1496
1.70
7.04
2.3
2.0
pmol/l
101.6
94.7
1.16
109
706
(3002030) Lymphocytes/100 leukocytes in Blood
239
1797
1.69
6.99
5.7
5.6
%
29.6
28.3
0.98
223
1650
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
70
370
2.05
6.51
2.1
2.3
umol/l
5.7
6.5
0.31
61
316
(3019069) Monocytes/100 leukocytes in Blood
232
1761
1.64
6.31
5.9
5.7
%
8.4
8.4
0.04
220
1631
(42870588) Differential panel, method unspecified - Blood
173
1219
1.67
6.31
5.2
5.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
109
678
1.80
6.21
3.6
3.4
ng/l
784.7
195.5
0.38
72
503
(3022096) Basophils/100 leukocytes in Blood
223
1688
1.62
6.05
5.6
5.6
%
0.6
0.7
1.26
211
1549
(3006504) Eosinophils/100 leukocytes in Blood
229
1753
1.61
5.88
5.7
5.4
%
3.1
2.7
2.28
216
1603
(3018010) Neutrophils/100 leukocytes in Blood
230
1776
1.59
5.60
5.5
5.4
%
55.3
57.3
1.74
215
1642
(3019309) Folate [Moles/volume] in Red Blood Cells
107
684
1.73
5.49
1.8
1.6
nmol/l
1001.1
1205.1
1.24
90
500
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
341
2901
1.67
5.49
7.3
6.8
u/l
75.1
76.0
0.21
328
2706
(3024561) Albumin [Mass/volume] in Serum or Plasma
204
1542
1.58
5.38
4.8
3.8
g/l
36.6
35.7
1.71
192
1426
(40768804) Tissue Pathology biopsy report
209
1598
1.56
5.19
2.1
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
243
1928
1.55
5.08
5.5
5.8
e9/l
0.2
0.2
2.51
218
1686
(3031040) Bacteria [#/volume] in Urine by Automated count
302
2534
1.56
4.76
4.9
4.6
e6/l
6.0
3697.1
—
5
34
(3019550) Sodium [Moles/volume] in Serum or Plasma
420
3843
2.04
4.70
19.6
14.3
mmol/l
139.5
139.7
1.00
411
3725
(3013005) Retinol [Moles/volume] in Serum or Plasma
8
8
10.15
4.53
1.3
1.8
umol/l
1.7
1.9
—
8
8
(3023103) Potassium [Moles/volume] in Serum or Plasma
420
3852
2.02
4.53
19.9
14.4
mmol/l
3.9
3.9
0.38
410
3724
(3001604) Monocytes [#/volume] in Blood
231
1849
1.50
4.41
5.5
5.4
e9/l
0.6
0.6
0.41
205
1590
(3019225) pH of Specimen
61
353
1.84
4.34
3.7
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
413
3778
1.89
4.31
15.9
12.7
mg/l
20.2
22.9
0.94
339
2929
(3052851) Hemolysis interference index of Serum or Plasma
25
103
2.51
4.21
2.7
3.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
231
1861
1.48
4.20
5.5
5.4
e9/l
0.0
0.0
0.29
205
1598
(3019198) Lymphocytes [#/volume] in Blood
235
1900
1.48
4.19
5.6
5.4
e9/l
2.0
1.9
0.27
210
1669
(3013826) Glucose [Moles/volume] in Serum or Plasma
256
2116
1.47
4.02
6.5
4.0
mmol/l
6.6
6.5
0.03
239
1963
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
402
3673
1.74
3.87
5.2
4.3
mmol/l
5.9
5.8
0.70
377
3333
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
140
1037
1.50
3.77
2.8
2.8
ng/l
786.3
1096.4
1.22
117
875
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
101
703
1.56
3.61
3.4
2.8
mmol/l
2.4
2.5
0.57
86
612
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
85
570
1.60
3.56
2.1
2.8
e6/l
2.8
3.4
0.22
38
278
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
63
2.76
3.53
4.6
2.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
205
1666
1.42
3.31
3.6
2.6
ug/l
105.8
106.8
0.02
189
1525
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
122
902
1.48
3.26
2.0
2.1
mg/l
2.7
3.1
1.38
102
763
(3001019) Free T4 and TSH panel - Serum or Plasma
33
172
1.99
3.23
1.9
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
127
952
1.46
3.16
6.0
6.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
34
3.29
3.07
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
55
344
1.68
3.03
1.5
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
254
2163
1.39
3.02
7.9
8.7
e9/l
3.8
4.0
0.80
226
1877
(3028717) Thiamine [Mass/volume] in Blood
5
5
10.09
2.98
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
96
691
1.49
2.91
1.3
1.3
u/ml
16.0
10.0
0.28
39
251
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
143
1114
1.41
2.85
2.4
2.1
u/l
124.0
180.1
1.69
133
1060
(3049717) Cytology report of Urine Cyto stain
23
110
2.15
2.83
2.3
2.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
117
880
1.44
2.83
2.2
2.4
umol/l
2873.6
8652.0
1.16
92
766
(3037522) Nuclear Ab [Titer] in Serum
75
516
1.54
2.81
1.4
1.4
titre
777.5
491.3
0.40
16
113
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
375
3439
1.48
2.78
6.2
5.3
mmol/mol
39.0
39.2
0.12
355
3188
(3037467) Urinalysis macro (dipstick) panel - Urine
298
2625
1.38
2.77
5.0
4.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
168
1351
1.38
2.77
3.5
3.6
e6/l
14.3
68.6
6.08
109
922
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
398
3698
1.56
2.74
4.5
4.2
mmol/l
4.7
4.8
0.45
373
3413
(40768797) Stomach Pathology biopsy report
74
511
1.53
2.72
1.3
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
421
3966
1.71
2.71
18.8
14.9
umol/l
75.3
71.9
0.87
421
3966
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
143
1123
1.40
2.70
3.1
2.2
u/l
58.9
57.1
0.12
134
1040
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
24
3.80
2.68
1.1
1.3
mmol/l
2.0
2.0
—
9
24
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
53
340
1.63
2.66
2.5
2.1
u/l
32.6
34.0
0.12
45
282
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
49
2.70
2.64
1.2
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
142
1119
1.39
2.62
3.0
3.1
e6/l
41.5
133.0
0.73
103
846
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
422
3986
1.69
2.58
11.4
9.9
u/l
24.4
24.1
0.11
410
3835
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
33
3.08
2.54
1.3
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
26
3.51
2.49
1.1
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
228
1947
1.34
2.48
5.2
5.4
umol/l
10.4
10.2
0.18
214
1836
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
167
1.85
2.47
17.5
7.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
49
315
1.62
2.45
1.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
68
472
1.52
2.45
1.5
2.1
ug/g
156.7
109.6
0.47
48
353
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
161
1307
1.36
2.45
3.0
3.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
34
2.98
2.42
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
395
3686
1.50
2.42
4.4
4.2
mmol/l
1.5
1.6
1.55
366
3389
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
274
2409
1.34
2.42
3.6
2.8
u/l
49.4
42.8
0.60
259
2238
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
109
834
1.40
2.37
1.8
1.6
mg/l
1.1
1.0
0.10
77
645
(3013512) EKG study
134
1063
1.37
2.34
4.3
3.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
53
2.49
2.29
1.2
1.0
u/ml
0.7
2.2
—
5
23
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
53
2.49
2.29
1.4
1.2
nmol/l
0.5
0.6
1.32
13
47
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
85
626
1.44
2.28
2.1
2.6
e6/l
0.9
1.1
0.36
38
327
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
96
723
1.41
2.28
1.4
1.3
iu/ml
19.4
33.6
1.00
25
217
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
66
2.32
2.27
1.4
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
402
3780
1.50
2.21
5.1
4.7
mmol/l
2.7
2.8
0.49
376
3468
(3000991) Gas panel - Venous blood
41
259
1.64
2.21
17.5
6.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
74
2.20
2.17
2.3
3.2
e9/l
4.7
4.6
0.04
16
74
(3044889) 12 lead EKG panel
290
2596
1.32
2.13
3.8
3.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
380
3544
1.41
2.11
15.3
12.0
ml/min/173m2
80.2
80.9
0.26
325
2874
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
110
1.95
2.09
2.3
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
57
0.00
2.06
0.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
76
2.15
2.05
2.3
3.5
%
61.1
58.9
0.32
16
76
(3021960) Folate [Moles/volume] in Serum or Plasma
110
863
1.36
2.04
1.6
1.5
nmol/l
20.8
22.1
0.42
96
729
(4010399)
43
281
1.58
2.04
1.3
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
163
1.76
2.03
1.5
1.4
iu/l
26.5
26.9
0.02
22
143
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
90
684
1.39
2.03
1.6
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
56
389
1.50
2.03
13.3
5.9
kpa
5.0
5.1
0.60
51
376
(3027801) Oxygen [Partial pressure] in Arterial blood
56
389
1.50
2.03
13.3
5.9
kpa
12.9
12.5
0.24
51
376
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
261
2316
1.29
1.98
3.2
3.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
19
98
1.98
1.98
1.3
1.2
—
154.0
—
0
5
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
98
759
1.37
1.97
1.8
1.7
pmol/l
499.4
19586430.5
0.78
83
628
(3017732) Neutrophils [#/volume] in Blood
38
243
1.61
1.97
2.1
2.5
e9/l
4.3
4.0
0.24
33
183
(3024928) Oxygen saturation in Venous blood
14
64
2.22
1.96
1.8
2.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
135
1.82
1.95
1.7
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
97
752
1.37
1.94
2.9
2.6
mosm/kgh2o
535.9
530.6
0.07
86
631
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
33
2.76
1.94
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
33
2.76
1.94
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
16
3.78
1.94
1.0
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
18
92
2.00
1.92
1.8
2.0
%
182.0
190.5
0.20
18
86
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
78
584
1.40
1.92
1.6
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
22
3.21
1.88
1.3
1.6
%
13.6
10.3
—
7
22
(3022217) INR in Platelet poor plasma by Coagulation assay
58
413
1.46
1.87
18.7
22.3
inr
1.5
1.2
0.69
13
54
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
46
2.43
1.86
1.3
1.3
nmol/l
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
434
4175
1.67
1.86
24.4
19.0
e9/l
256.6
256.0
0.07
427
4057
(3030467) Casts [#/volume] in Urine by Automated count
128
1042
1.32
1.85
2.8
3.0
e6/l
0.2
0.4
1.99
88
771
(3035350) Ketones [Presence] in Urine by Test strip
216
1883
1.28
1.84
3.9
3.8
estimate
0.0
0.0
0.00
32
354
(3026361) Erythrocytes [#/volume] in Blood
434
4177
1.67
1.83
24.4
19.0
e12/l
4.4
4.4
0.64
426
4046
(3003396) Base excess in Arterial blood by calculation
55
390
1.47
1.81
13.5
5.9
mmol/l
1.2
1.3
0.07
42
310
(3010813) Leukocytes [#/volume] in Blood
434
4178
1.66
1.81
24.5
19.0
e9/l
6.6
6.6
0.11
425
4044
(3027945) Reticulocytes/100 erythrocytes in Blood
54
382
1.47
1.80
2.2
2.2
%
1.7
1.8
0.44
44
328
(3002256) Pathology report gross observation
66
487
1.41
1.77
1.2
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
267
1.55
1.75
1.5
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
18
3.36
1.75
1.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
65
480
1.41
1.74
4.0
4.2
%
31.9
33.2
0.53
52
311
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
34
219
1.60
1.73
1.4
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
21
118
1.82
1.73
1.3
1.3
—
18.0
—
0
9
(4062490)
8
30
2.70
1.73
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
48
2.32
1.71
1.8
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
364
3408
1.32
1.67
18.7
14.0
%
38.5
39.0
0.36
273
2432
(3003338) MCHC [Mass/volume]
342
3179
1.29
1.63
20.4
16.8
g/l
331.9
331.1
1.03
337
3153
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
32
2.53
1.60
1.3
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
108
876
1.30
1.59
1.4
1.2
u/ml
0.8
2.3
1.45
22
226
(3007164) IgA [Mass/volume] in Serum or Plasma
94
749
1.32
1.57
1.4
1.4
g/l
2.0
2.3
1.26
54
433
(1616796) Gas panel - Central venous blood
13
64
2.06
1.55
4.2
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
140
1.68
1.48
1.7
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
237
1.52
1.47
1.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
408
1.40
1.45
1.7
1.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
16
3.15
1.44
4.8
2.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
16
3.15
1.44
1.4
1.6
nmol/l
115.8
160.7
—
5
16
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
47
340
1.43
1.43
1.4
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
409
3921
1.38
1.40
14.6
11.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
215
1918
1.23
1.38
4.1
3.8
estimate
0.0
0.0
0.50
36
347
(3023511) Choriogonadotropin [Units/volume] in Urine
15
82
1.86
1.37
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
119
996
1.26
1.36
1.5
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
147
1261
1.24
1.36
3.3
3.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
17
2.96
1.36
1.8
2.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
17
2.96
1.36
2.4
3.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
16
90
1.81
1.34
1.4
1.3
mg/l
394.7
529.2
1.38
16
84
(3044290) Cell count panel - Cerebral spinal fluid
13
68
1.94
1.34
1.5
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
24
2.52
1.30
2.5
3.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
34
2.38
1.29
1.3
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
18
2.80
1.29
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
55
2.02
1.28
1.5
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
140
1202
1.24
1.28
3.2
2.8
u/l
26.7
29.6
1.58
131
1144
(3051611) Lipemic interference index of Serum or Plasma
8
35
2.31
1.27
3.0
3.8
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
92
1.77
1.26
1.3
1.3
—
13.5
—
0
7
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
373
3544
1.27
1.25
4.1
3.7
mmol/l
1.2
1.2
0.05
342
3231
(3023410) Appearance of Cerebral spinal fluid
8
36
2.24
1.25
1.7
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
25
2.42
1.24
1.7
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
85
1.79
1.24
3.3
3.2
mg/l
15.9
24.7
—
9
50
(3021601) Nitrite [Presence] in Urine by Test strip
211
1895
1.21
1.23
5.7
5.3
estimate
0.0
0.0
0.50
36
357
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
19
2.65
1.22
1.2
1.6
—
—
—
0
0
(1002224) Polysomnography panel
22
141
1.59
1.19
1.1
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
54
414
1.34
1.19
1.7
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
94
1.73
1.19
1.8
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
108
909
1.25
1.18
3.2
3.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
50
2.02
1.17
1.4
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
20
2.52
1.15
2.0
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
51
1.98
1.12
1.8
1.7
%
69.1
58.5
—
10
51
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
66
1.84
1.10
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
66
1.84
1.10
1.5
1.3
—
—
—
0
0
(4211845)
5
21
2.40
1.09
2.4
3.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
7
33
2.14
1.06
1.6
1.2
nmol/l
211.6
386.7
—
7
27
(3032773) Endomysium IgG Ab [Titer] in Serum
7
33
2.14
1.06
1.0
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
42
317
1.36
1.04
16.7
6.4
g/l
120.0
119.3
0.09
37
310
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
66
532
1.28
1.04
1.8
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
185
1663
1.19
1.03
10.1
8.8
e9/l
0.0
0.0
0.75
151
1356
(3022948) Iron [Moles/volume] in Serum or Plasma
67
542
1.28
1.03
3.1
2.1
umol/l
12.3
13.1
0.48
62
490
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
14
83
1.71
1.02
1.3
1.2
mmol/l
3.4
3.8
1.05
14
76
(3023368) Bacteria identified in Blood by Culture
105
895
1.22
1.02
4.4
3.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
68
1.79
1.01
1.1
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
41
310
1.35
1.01
4.1
3.0
mmol/l
1.5
1.9
0.30
35
242
(3000093) Morphology [Interpretation] in Blood Narrative
7
35
2.02
1.00
1.9
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
56
446
1.29
0.97
1.4
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
125
1.54
0.95
3.6
3.2
g/l
0.4
0.1
—
10
40
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
93
1.63
0.95
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
101
1.61
0.94
1.8
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
412
1.30
0.94
3.2
3.8
ug/l
58.5
19.1
0.31
43
343
(36304419) Bacteria [Presence] in Urine
117
1017
1.20
0.94
3.0
2.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
28
2.16
0.92
2.2
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
102
1.59
0.91
1.8
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
102
1.59
0.91
1.8
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
94
1.62
0.91
1.3
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
116
1010
1.20
0.91
4.1
3.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
63
1.76
0.91
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
95
1.60
0.88
1.5
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
128
1.51
0.87
1.8
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
24
170
1.43
0.87
3.0
2.4
%
1.2
1.2
0.04
24
170
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
80
1.64
0.85
1.8
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
275
1.34
0.85
2.8
2.2
e9/l
70.6
72.0
0.10
28
199
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
31
1.95
0.84
1.7
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
31
1.95
0.84
2.5
2.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
45
1.79
0.84
2.8
1.4
pg
31.6
31.6
—
8
45
(3017143) Hepatitis C virus Ab [Presence] in Serum
46
365
1.29
0.84
1.8
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
47
1.71
0.81
1.3
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
235
1.34
0.78
1.5
1.8
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
27
0.00
0.77
0.0
3.1
—
21.4
—
0
18
(3004789) Transferrin [Mass/volume] in Serum or Plasma
61
507
1.23
0.77
3.2
2.1
g/l
2.4
2.4
0.25
56
461
(3009508) Creatinine [Moles/volume] in Urine
121
1074
1.17
0.76
3.5
2.9
mmol/l
7.7
6.9
1.19
108
901
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
34
1.77
0.76
2.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
67
1.66
0.75
1.3
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
57
472
1.24
0.75
3.5
2.1
%
19.7
22.8
1.28
48
405
(3036603) Volume of Urine
5
24
2.09
0.74
1.2
1.4
—
2032.2
—
0
5
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
100
1.52
0.73
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
100
1.52
0.73
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
100
1.52
0.73
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
100
1.52
0.73
1.3
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
25
2.01
0.73
1.2
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
25
2.01
0.73
2.0
1.7
g/l
0.9
1.1
—
5
25
(3050129) First trimester maternal screen panel - Serum or Plasma
17
117
1.47
0.72
1.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
186
1.36
0.71
3.1
3.0
mmol/l
1.0
2.0
0.86
17
140
(3023419) Bacteria identified in Sputum by Culture
7
40
1.76
0.71
2.3
2.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
57
1.59
0.71
1.7
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
93
813
1.18
0.71
4.1
4.1
kg/l
1.0
1.0
0.22
25
115
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
118
1.46
0.70
1.1
1.3
miu/ml
332.9
262.9
—
8
61
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
85
1.54
0.69
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
73
626
1.20
0.69
1.9
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
59
1.54
0.68
1.6
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
59
1.54
0.68
1.4
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
27
1.86
0.68
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
449
0.78
0.68
6.3
6.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
162
1.38
0.67
1.1
1.2
—
—
—
0
0
(4306422)
7
43
1.64
0.67
1.3
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
12
78
1.55
0.66
1.9
2.0
g/l
114.6
127.1
—
7
52
(3027944) Amphetamines [Presence] in Urine
15
103
1.47
0.65
1.9
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
156
1431
1.14
0.63
11.8
7.6
inr
1.4
1.2
0.87
37
410
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
50
1.61
0.61
3.4
3.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
19
139
1.38
0.61
3.6
3.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
14
97
1.46
0.59
9.3
2.1
g/l
3.2
3.8
1.29
14
91
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
202
1.30
0.58
2.8
2.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
59
505
1.19
0.58
2.0
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
112
1010
1.14
0.58
3.5
3.0
mg/l
71.3
112.2
0.21
76
610
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
114
1030
1.14
0.57
1.7
1.6
mmol/l
1.3
1.3
0.77
102
877
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
98
1.44
0.57
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
55
1.46
0.56
3.6
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
819
0.86
0.56
1.5
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
25
317
0.78
0.56
1.5
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
146
1343
1.13
0.56
4.1
3.5
ng/l
37.9
62.4
0.38
104
914
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
90
1.46
0.56
1.6
2.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
82
1.48
0.55
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
82
1.48
0.55
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
82
1.48
0.55
2.0
2.3
u/ml
0.5
0.4
—
5
51
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
341
1.22
0.54
4.0
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
89
795
1.15
0.53
2.7
2.4
e6/l
5.7
5.8
0.05
77
696
(3021901) Oxygen saturation in Capillary blood
9
62
1.46
0.53
2.1
2.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
16
117
1.38
0.53
3.6
3.1
mmol/l
24.3
24.7
0.46
16
110
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
135
1.35
0.52
1.9
2.3
u/l
4038.0
3343.2
—
9
57
(3007853) Bacteria identified in Skin by Aerobe culture
46
390
1.20
0.51
1.7
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
109
1.39
0.51
1.3
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
162
1.31
0.51
1.7
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
110
1.38
0.49
4.5
5.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
93
1.41
0.48
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
28
227
1.25
0.48
4.2
4.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
92
831
1.13
0.47
4.4
4.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
68
1.48
0.47
2.3
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
92
1014
0.88
0.47
4.7
4.0
estimate
0.0
0.0
0.50
34
348
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
94
1.39
0.46
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
41
350
1.19
0.44
1.7
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
43
369
1.18
0.44
1.6
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
416
1.17
0.43
1.7
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
31
258
1.22
0.43
4.2
2.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
56
1.44
0.42
3.6
2.4
mmol/l
4.1
3.9
—
8
56
(3035285) Chloride [Moles/volume] in Venous blood
8
56
1.44
0.42
3.6
2.4
mmol/l
105.1
106.7
—
8
56
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
58
1.39
0.41
1.0
1.1
—
19.2
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
33
1.52
0.41
1.6
1.2
—
—
—
0
0
(4268621)
5
33
1.52
0.41
3.0
2.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
278
1.20
0.41
1.3
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
150
1.28
0.41
1.3
1.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
35
1.43
0.39
1.0
1.5
%
89.4
89.7
—
5
35
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
66
1.37
0.38
1.9
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
66
1.37
0.38
1.2
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
36
1.39
0.38
1.4
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
107
1.32
0.37
1.6
1.3
ug/g
252.1
303.9
—
8
60
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.37
1.0
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
37
1.36
0.37
1.6
1.0
—
—
—
0
0
(44790049)
6
43
1.40
0.35
1.3
1.4
—
—
—
0
0
(44806118)
6
43
1.40
0.35
1.3
1.4
—
—
—
0
0
(44790048)
6
43
1.40
0.35
1.3
1.4
—
—
—
0
0
(44790047)
6
43
1.40
0.35
1.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
178
0.78
0.35
1.5
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
30
258
1.17
0.32
1.3
2.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
114
1069
1.09
0.31
4.4
3.7
mg/mmol
13.2
7.9
0.26
73
640
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
53
1.33
0.31
1.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
54
1.30
0.30
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
55
1.28
0.30
1.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
55
1.28
0.30
1.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
55
1.28
0.30
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
117
1242
0.92
0.30
2.7
2.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
213
1.18
0.29
1.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.3
1.4
—
—
—
0
0
(4034850)
15
121
1.25
0.29
12.7
7.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
94
1.28
0.28
1.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
85
1.30
0.28
1.2
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
178
1.19
0.26
1.3
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
45
406
1.12
0.26
1.8
2.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
224
0.84
0.26
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
44
398
1.12
0.25
1.2
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
133
1.21
0.24
1.9
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
81
0.74
0.24
1.0
4.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
42
1.19
0.21
2.0
2.1
—
875.0
—
0
5
(3013727) Leukocytes other/100 leukocytes in Blood
0
11
0.00
0.21
0.0
2.7
—
56.3
—
0
11
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
145
0.82
0.21
1.3
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
1.7
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
90
1.23
0.19
1.4
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
33
299
1.11
0.19
4.8
4.0
%
0.4
0.2
0.27
11
78
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
217
0.87
0.19
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
49
454
1.09
0.19
6.0
4.9
ug/l
9.7
2.8
0.44
44
392
(3038515) Glucose [Moles/volume] in Venous blood
11
91
1.21
0.17
4.2
2.7
mmol/l
7.8
7.3
0.33
11
91
(3025159) Blasts/100 leukocytes in Blood
25
278
0.89
0.17
5.0
4.2
%
0.0
0.2
—
6
61
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
62
1.13
0.17
2.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
62
1.13
0.17
1.1
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
34
314
1.09
0.14
5.0
4.0
%
1.2
0.9
0.16
12
85
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
84
1.19
0.14
1.2
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
149
0.87
0.13
1.8
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
100
0.80
0.13
1.5
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
209
1.11
0.13
1.6
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
11
95
1.16
0.11
4.2
2.6
mmol/l
1.6
1.5
0.29
11
95
(40761535) Cells panel - Urine sediment
27
291
0.92
0.11
3.6
3.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
44
1.14
0.10
2.0
2.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.0
—
1.0
—
0
15
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.4
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
184
1.09
0.09
1.5
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
54
1.11
0.09
4.3
3.1
u/ml
41.7
75.3
—
6
54
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
57
1.05
0.08
2.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
60
0.83
0.08
1.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
195
1.08
0.08
4.2
4.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
28
264
1.06
0.08
3.6
3.0
ug/l
0.6
0.7
0.52
18
183
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
147
1444
1.03
0.07
4.5
4.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
75
0.80
0.07
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
137
1.10
0.07
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
81
0.86
0.07
2.0
2.3
—
—
—
0
0
(4035726)
34
324
1.05
0.07
1.2
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
91
0.88
0.07
1.3
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
27
282
0.95
0.04
5.8
4.0
%
0.3
0.6
—
7
57
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
91
1.10
0.04
1.1
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
37
359
1.03
0.03
4.5
4.2
%
20.3
21.3
0.12
18
184
(40768793) Breast Pathology biopsy report
14
149
0.94
0.03
1.1
1.3
—
—
—
0
0
(4094501)
10
92
1.09
0.03
1.2
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
22
212
1.04
0.02
5.7
6.8
mmol/l
23.8
24.9
0.33
16
201
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
12
113
1.06
0.02
1.3
3.4
—
2.7
—
0
10
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
123
1.06
0.01
1.5
1.6
—
215.0
—
0
8
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
296
0.98
0.00
2.5
2.4
ml/min/173m2
66.8
68.6
0.11
18
118
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
12
115
1.04
0.00
2.3
1.5
ug/l
96.3
231.4
2.05
12
104
(3008898) HLA-B27 [Presence]
17
165
1.03
0.00
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
138
1.01
0.00
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
31
308
1.01
0.00
5.8
3.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
129
1.01
0.00
2.1
1.9
—
—
—
0
0
(3020891) Body temperature
13
129
1.01
0.00
5.5
5.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
199
1.01
0.00
1.4
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
289
1.00
0.00
1.4
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
58
0.86
0.00
2.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
68
0.88
0.00
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
140
1.00
0.00
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
84
0.95
0.00
1.5
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
53
0.94
0.00
4.2
3.5
—
448.0
—
0
5
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
63
0.95
0.00
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
59
1.02
0.00
2.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
24.5
—
0
8
(3023183) Ammonium ion [Moles/volume] in Plasma
6
60
1.00
0.00
4.8
3.5
umol/l
42.8
33.7
—
6
51
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1.0
—
0
6
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
3.5
—
0
6
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
15
150
1.00
0.00
1.1
1.6
—
5.9
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
0
5
0.00
-0.00
0.0
1.2
—
5.8
—
0
5
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
0.0
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
-0.00
0.0
1.2
—
1.8
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_THYROIDNASOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_THYROIDNASOTH | 1.444 [1.16, 1.8] | 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.115 |
During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 1145 females with E4_THYROIDNASOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_THYROIDNASOTH | 0.919 [0.68, 1.25] | 0.585 |
| Birth year | 0.988 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 66 out of 391 males with E4_THYROIDNASOTH died.
Mortality risk
Mortality risk for people of age
years, who have E4_THYROIDNASOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.15% | 0.156% |
| 5 | 0.893% | 1.064% |
| 10 | 2.105% | 2.826% |
| 15 | 3.935% | 5.346% |
| 20 | 6.989% | 8.95% |
Relationships between endpoints
↥Index endpoint: E4_THYROIDNASOTH – Disorder of thyroid, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data